RayeJBudwayMD
General Surgery • Bethel Park, PABreast, Trauma Surgery & Surgical Critical Care
Budway surgical
Dr. Budway is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2000 Oxford Dr
Ste 301
Bethel Park, PA 15102Phone+1 412-942-7850Fax+1 412-942-7831
Education & Training
UPMC Medical EducationFellowship, Surgical Critical Care, 1994 - 1995
Allegheny Health Network Medical Education Consortium (AGH)Residency, Surgery, 1988 - 1993
Drexel University College of MedicineClass of 1988
Grove City CollegeBS in Engineering, Chemical Engineering, Magna cum laude, 1980 - 1984
Certifications & Licensure
PA State Medical License 1990 - 2024- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Pittsburgh Magazine Castle Connolly, 2011-2021
- Fellow (FACS) American College of Surgeons
Clinical Trials
- PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score Start of enrollment: 2012 May 01
- Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry Start of enrollment: 2015 Nov 01
Publications & Presentations
PubMed
- 4 citationsEffects of aerobic exercise on neurocognitive function in postmenopausal women receiving endocrine therapy for breast cancer: The Exercise Program in Cancer and Cognit...Catherine M Bender, Susan M Sereika, Amanda L Gentry, Cheryl Cuglewski, Jennie Duquette
Psycho-Oncology. 2024-02-01 - Combined 70- and 80-gene signatures identify tumors with genomically luminal biology responsive to neoadjuvant endocrine therapy and are prognostic of 5-year outcome i...James V Pellicane, Peter D Beitsch, David T Rock, Raye J Budway, Carrie L Dul
Surgical Oncology. 2022-12-01 - 3 citationsGenomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant Therapy.Pat W Whitworth, Peter D Beitsch, Mary K Murray, Paul D Richards, Angela Mislowsky
JCO Precision Oncology. 2022-09-01
Press Mentions
St. Clair Health Now Using Tyrer-Cuzick Risk Assessment Calculator for Breast CancerOctober 14th, 2021
Committees
- member, Oncology Steering Committee 2019 - Present
- Member, Infection Control 2018 - Present
- Member, Credentialing Committee 2018 - Present
- Cancer Liaison Physician, Cancer Committee 2011 - Present
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
